Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
Journal of Crohn'S & Colitis
|
December 22, 2010
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study
Pascal Juillerat, Valérie Pittet, Jean-Luc Bulliard, et al.
Inflammatory Bowel Diseases
|
December 18, 2014
Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort
Pascal Juillerat, Harry Sokol, Florian Froehlich, et al.
Swiss Medical Weekly
|
September 28, 2023
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice
Laura Rossier, Christoph Matter, Emanuel Burri, et al.
Advances in Therapy
|
November 20, 2020
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, et al.
Inflammatory Bowel Diseases
|
October 21, 2016
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease
Christian Mottet, Alain M Schoepfer, Pascal Juillerat, et al.
Microorganisms
|
August 27, 2021
Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis
Luisa Denoth, Pascal Juillerat, Andreas E Kremer, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)
|
August 28, 2024
A UHPLC-MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption
Jean-Christophe Prost, Felix Brunner, Cédric Bovet, et al.
Plos One
|
July 3, 2018
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
Bahtiyar Yilmaz, Marianne R Spalinger, Luc Biedermann, et al.
Advances in Therapy
|
November 30, 2021
A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, et al.
The American Journal of Gastroenterology
|
June 18, 2019
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease
Laure F Pittet, Charlotte M Verolet, Pierre Michetti, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
Journal of Crohn'S & Colitis
|
December 22, 2010
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study
Pascal Juillerat, Valérie Pittet, Jean-Luc Bulliard, et al.
Inflammatory Bowel Diseases
|
December 18, 2014
Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort
Pascal Juillerat, Harry Sokol, Florian Froehlich, et al.
Swiss Medical Weekly
|
September 28, 2023
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice
Laura Rossier, Christoph Matter, Emanuel Burri, et al.
Advances in Therapy
|
November 20, 2020
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, et al.
Inflammatory Bowel Diseases
|
October 21, 2016
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease
Christian Mottet, Alain M Schoepfer, Pascal Juillerat, et al.
Microorganisms
|
August 27, 2021
Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis
Luisa Denoth, Pascal Juillerat, Andreas E Kremer, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)
|
August 28, 2024
A UHPLC-MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption
Jean-Christophe Prost, Felix Brunner, Cédric Bovet, et al.
Plos One
|
July 3, 2018
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
Bahtiyar Yilmaz, Marianne R Spalinger, Luc Biedermann, et al.
Advances in Therapy
|
November 30, 2021
A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, et al.
The American Journal of Gastroenterology
|
June 18, 2019
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease
Laure F Pittet, Charlotte M Verolet, Pierre Michetti, et al.
Page
of 11